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Abstract 
Background: The origin of collagen autoimmune diseases is not fully understood. Some 
studies postulate a mechanism of molecular mimicry or heterologous immunity following 
viral infections triggering autoimmunity. Apart from infections, other exogenous factors such 
as visible light or X-rays have been reported to incite autoimmunity. Case Report: We report 
a case of histologically and serologically confirmed subacute lupus erythematosus (SCLE) 
following radiotherapy for breast cancer. Discussion: The close temporal and spatial 
correlation between radiotherapy and onset of SCLE in this patient suggests that an 
autoimmune reaction may have been triggered locally by functionally altering the immune 
system and breaking self-tolerance. © 2013 S. Karger AG, Basel 
Case Report 
A 72-year-old woman underwent breast cancer surgery and received adjuvant systemic 
treatment with the estrogen receptor antagonist tamoxifen 20 mg/day, which was discon-
tinued after the patient developed a generalized skin rash about two weeks after the 
initiation of tamoxifen. This rash was clinically and histologically diagnosed as erythema 
exsudativum multiforme, which rapidly resolved under systemic treatment with predniso-
lone. Tamoxifen was discontinued. The patient afterwards received radiotherapy of the left 
breast. A cumulative dose of 40 Gy in 15 fractions was administered and was initially well 
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tolerated by the patient. After finishing radiotherapy, our patient developed a painless 
maculopapular erythema on the left breast limited to the irradiated area.  
Histology of a skin biopsy taken from the left breast showed an acute interface dermati-
tis with vacuolization of the dermo-epidermal junction, apoptotic keratinocytes in the basal 
epidermis and a mild, predominantly lymphocytic, infiltrate within the superficial dermis 
and with few admixed neutrophils and eosinophilic granulocytes. 
These histological changes were consistent with subacute cutaneous lupus erythemato-
sus (SCLE). Because of the presence of eosinophilic granulocytes in the inflammatory 
infiltrate, a fixed drug eruption was considered a differential diagnosis. An allergic reaction 
to tamoxifen was ruled out by a negative scratch-patch test. 
Serology revealed elevated titers for antinuclear antibodies 1:2,560, anti-SS-A at >3,400 
U/ml, anti-SS-B at >3,400 U/ml and rheumatoid factor at 41 IU/ml. Complement compo-
nents (C3 and C4) were within normal limits and urine analysis was unremarkable. 
Based on the patient’s history, the clinical presentation of the skin lesions, serologic 
results, histopathology and allergy testing, a diagnosis of SCLE – presumably triggered by 
radiotherapy – was made. 
The administration of topical corticosteroids and systemic hydroxychloroquine at 400 
mg/day led to a total disappearance of the lesions on the left breast within 6 weeks.  
Discussion 
SCLE was first characterized by Sontheimer et al. [1] in 1979 as a recurring, nonfixed, 
superficial, nonscarring, photosensitive form of lupus erythematosus with a papulosqua-
mous or an anular pattern, lupus-specific histopathology, lack of systemic involvement and a 
high association with circulating antinuclear and anti-SS-A in 80% antibodies, the latter 
occurring of the cases. Anti-SS-B auto-antibodies are found less frequently. Direct immuno-
fluorescence remains negative in up to 40% of the cases [1, 2]. 
Triggering agents for SCLE have been well recognized. Best described is the impact of 
UV light on the development of SCLE [3]. Regarding our patient, this important trigger could 
be ruled out. 
Apart from phototriggering, many drugs have been related to the induction of SCLE. 
They include NSAID, tetracyclines and antihypertensive drugs among many others. Fumal et 
al. [4] previously described two cases of tamoxifen-induced SCLE starting after several years 
of treatment with tamoxifen. Tamoxifen seems to be an unlikely trigger factor for SCLE in 
our patient because tamoxifen had been discontinued two months before the appearance of 
the skin lesions on the breast. Additionally, scratch-patch testing for tamoxifen was negative. 
Another differential diagnosis includes a rare and controversial entity called Rowell’s 
syndrome, which describes the clinical association of lupus erythematosus with erythema 
multiforme-like lesions and a speckled pattern of antinuclear antibodies (major criteria). 
The minor criteria include chilblains, anti-Ro and/or anti-La antibodies and positive 
rheumatoid factor. All three major criteria and at least one minor criteria are required to 
establish the diagnosis of Rowell’s syndrome. The clinical and serological criteria (histologi-
cal findings consistent with erythema multiforme and SCLE, elevated titers for antinuclear 
antibodies 1:2,560, anti-SS-A at >3,400 U/ml, anti-SS-B at >3,400 U/ml and rheumatoid 
factor at 41 IU/ml ) provide strong evidence for the diagnosis of Rowell’s syndrome in our 
case but would not explain the limitation of SCLE to the irradiation site on the left breast two 
months after the appearance of the erythema multiforme. 
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Radiotherapy most frequently induces acute radiation dermatitis. Other acute cutaneous 
reactions to radiotherapy are contact dermatitis, Sweet’s syndrome, lichen planus, pemphi-
gus, cutaneous hypersensitivity syndromes such as erythema multiforme as well as 
nonspecific hypersensitivity reactions like urticaria, localized Stevens-Johnson syndrome or 
even toxic epidermal necrolysis.  
Radiation recall dermatitis refers to the rare appearance of a maculopapular rash in 
previously irradiated skin after the administration of drugs, especially chemotherapeutic 
agents or antibiotics [5, 6]. Radiation recall dermatitis typically develops within days or 
weeks after the administration of the drug. The diagnosis of radiation recall dermatitis in our 
case can be ruled out as tamoxifen was stopped prior to radiotherapy. 
Fleck et al. [7] reported the association of radiotherapy with collagen vascular disorders 
such as CREST, discoid lupus, acute lupus erythematosus, Sjögren’s syndrome and derma-
tomyositis in patients with preexisting collagen diseases. So far, radiotherapy inducing SCLE 
has been described in the literature only once before: Balabanova et al. [8] reported on an 
elderly female patient suffering from nondifferentiated lobular breast carcinoma with 
metastases in the axillary lymph nodes who developed an erythematous scaly eruption of 
the left thoracic area following radiotherapy of the area and was clinically, immunologically 
and histologically diagnosed as having SCLE. 
Conclusion 
The ethiopathogenesis of SCLE skin lesions is the result of 4 sequential stages: (1) inher-
itance of susceptibility genes; (2) loss of tolerance/induction of autoimmunity; (3) expan-
sion/maturation of autoimmune responses, and (4) tissue injury/disease induction resulting 
from various autoimmune effector mechanisms [9]. It has been described that ionizing 
radiation can functionally alter the immune system and break self-tolerance [10]. In our 
case, the close temporal and spatial correlation between radiotherapy and onset of SCLE 
suggests that an autoimmune reaction may have been triggered locally, e.g. by the presenta-
tion of an auto-antigen and the induction of a danger milieu favoring immune recognition in 
the setting of radiodermatitis [11]. While we lack formal proof for this interpretation, the 
patient’s history and further workup exclude most other reported associations, leaving us 
with radiotherapy as the most likely trigger of SCLE in this case. 
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Fig. 1. Maculopapular eruption appearing after radiotherapy limited to the irradiation site on the left 
breast. 
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Fig. 2. Histopathology of a papule within the affected area of the left breast showing acute interface 
dermatitis with vacuolization of the dermo-epidermal junction, apoptotic keratinocytes in the basal 
epidermis and a mild predominantly lymphocytic infiltrate within the superficial dermis with a few 
admixed neutrophils and eosinophilic granulocytes. 
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